Daiwa Securities Group Inc. - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 161 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2018. The put-call ratio across all filers is 1.05 and the average weighting 0.1%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$11
-26.7%
4260.0%0.00%
Q2 2023$15
+36.4%
4260.0%0.00%
Q1 2023$11
-35.3%
4260.0%0.00%
Q4 2022$17
-99.9%
426
+8.1%
0.00%
Q3 2022$13,000
-7.1%
3940.0%0.00%
Q2 2022$14,0000.0%394
+29.2%
0.00%
Q1 2022$14,000
-30.0%
3050.0%0.00%
Q4 2021$20,000
-9.1%
305
-14.6%
0.00%
Q3 2021$22,000
+29.4%
357
+73.3%
0.00%
Q2 2021$17,000
+21.4%
2060.0%0.00%
Q1 2021$14,000
-6.7%
206
+6.7%
0.00%
Q4 2020$15,000
-40.0%
193
-66.8%
0.00%
Q3 2020$25,000
+56.2%
581
+2.7%
0.00%
Q2 2020$16,0000.0%5660.0%0.00%
Q1 2020$16,000
-52.9%
566
+4.8%
0.00%
Q4 2019$34,000
+100.0%
540
-9.8%
0.00%
Q3 2019$17,000
+6.2%
5990.0%0.00%
Q2 2019$16,000
+45.5%
5990.0%0.00%
Q1 2019$11,000
+83.3%
599
+25.6%
0.00%
Q4 2018$6,000
-33.3%
4770.0%0.00%
Q3 2018$9,000
+50.0%
4770.0%0.00%
Q2 2018$6,000
+100.0%
4770.0%0.00%
Q1 2018$3,0004770.00%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q4 2018
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 908,474$24,410,69622.12%
Western Financial Corp/CA 820,239$22,039,82216.16%
JOHNSON & JOHNSON 247,598$6,652,9582.45%
WEALTH EFFECTS LLC 164,750$4,426,8352.19%
M28 Capital Management LP 67,400$1,811,0382.08%
Privium Fund Management B.V. 259,036$6,960,2982.07%
Evolutionary Tree Capital Management, LLC 51,266$1,377,5171.78%
Avidity Partners Management LP 1,063,897$28,586,9121.15%
SECTORAL ASSET MANAGEMENT INC 157,552$4,233,4220.82%
Vivo Capital, LLC 137,411$3,692,2340.40%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders